Mixed Results for Novel Lupus Drug in Mid-Stage Trial
(MedPage Today) -- An investigational biologic agent with an entirely new mechanism of action appeared effective for limiting joint involvement in systemic lupus erythematosus (SLE), results from a phase II randomized trial indicated.
Lupus patients...
Source: MedPage Today Rheumatology - Category: Rheumatology Source Type: news
More News: Lupus | Rheumatology